Concepedia

Author

Mark Keegan

Mayo ClinicORCID

Also Known As

M Keegan, M. Keegan, M.R. Keegan, Mark Keegan

36

Publications

1.5K

Citations

8

H-Index

22

Concepts

All Affiliations

Mayo ClinicSelecta Biosciences (United States)
MK

About

Mark Keegan is an author at Mayo Clinic specializing in medicine, humoral immunity, and cell transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

537

2

Public Health

1

1

26

3

Allergy

1

1

81

4

Cell Biology

1

1

81

5

Epidemiology

1

1

26

Mark Keegan

×

7

Publications

1.4K

Citations

7

H-Index

YearCitations

Plasma exchange for severe attacks of CNS demyelination: Predictors of response

Mark Keegan, Alvaro A. Pineda, Robyn L. McClelland,

Neurology

2002

594

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

Mark Keegan, Fatima König, Robyn L. McClelland,

The Lancet

2005

430

Genetic risk factors for anterior cruciate ligament ruptures: <i>COL1A1</i> gene variant

Michael Posthumus, Alison V. September, Mark Keegan,

British Journal of Sports Medicine

2009

194

Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates

Christopher C. Fraser, David H. Altreuter, Petr O. Ilyinskii,

Vaccine

2014

81

Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration

Isobel A. Scarisbrick, Rachel Linbo, Alexander G. Vandell,

Biological Chemistry

2008

81

Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation

Christine Doyle, J. F. Fielding, H. Holloway,

Gastroenterology

1995

26

Development and preclinical evaluation of SEL-068, a novel <i>targeted</i> Synthetic Vaccine Particle ( <i>t</i> SVP™) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine (75.11)

Lynnelle A. Pittet, David H. Altreuter, Petr O. Ilyinskii,

The Journal of Immunology

2012

16

Page 1